Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rosanel Amaro, Meropi Panagiotarakou, Victoria Alcaraz & Antoni Torres. (2018) The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis. Expert Review of Respiratory Medicine 12:8, pages 683-691.
Read now
Read now
Peter Greally, Paul Whitaker & Daniel Peckham. (2012) Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Current Medical Research and Opinion 28:6, pages 1059-1067.
Read now
Read now
Martha K Daddario, Jennifer K Hagerman & Michael E Klepser. (2010) Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis. Infection and Drug Resistance 3, pages 123-132.
Read now
Read now
Jennifer R Weiner, Edmond L Toy, Patricia Sacco & Mei Sheng Duh. (2008) Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature. Expert Opinion on Pharmacotherapy 9:5, pages 751-766.
Read now
Read now
Articles from other publishers (10)
Lean Franzl Yao, Kiki Ferawati, Kongmeng Liew, Shoko Wakamiya & Eiji Aramaki. (2023) Disruptions in the Cystic Fibrosis Community’s Experiences and Concerns During the COVID-19 Pandemic: Topic Modeling and Time Series Analysis of Reddit Comments. Journal of Medical Internet Research 25, pages e45249.
Crossref
Crossref
Marcus Hill, Matthew Twigg, Emer A. Sheridan, John G. Hardy, J. Stuart Elborn, Clifford C. Taggart, Christopher J. Scott & Marie E. Migaud. (2019) Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications. Pharmaceutics 11:8, pages 379.
Crossref
Crossref
Aukje C Bos, Johan W Mouton, Mireille van Westreenen, Eleni-Rosalina Andrinopoulou, Hettie M Janssens & Harm A W M Tiddens. (2017) Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?. Journal of Antimicrobial Chemotherapy 72:12, pages 3435-3442.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
29
35
.
Michael N. Neely & Michael D. Reed. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1433
1452.e10
.
Warren Lenney, Frank Edenborough, Pearl Kho & John M. Kovarik. (2011) Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. Journal of Cystic Fibrosis 10:1, pages 9-14.
Crossref
Crossref
Matthew E. Falagas, Georgia Sideri, Ioanna P. Korbila, Evridiki K. Vouloumanou, John H. Papadatos & Dimitris A. Kafetzis. (2010) Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatric Pulmonology 45:11, pages 1135-1140.
Crossref
Crossref
Natascia Corti, Alexander Imhof & Christa Wenger. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
461
489
.
Dominique Hubert, Sylvie Leroy, Raphaële Nove-Josserand, Marlène Murris-Espin, Laurent Mely, Stéphane Dominique, Bertrand Delaisi, Pearl Kho & John M Kovarik. (2009) Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis. Journal of Cystic Fibrosis 8:5, pages 332-337.
Crossref
Crossref
Victoria L. Campodónico, Mihaela Gadjeva, Catherine Paradis-Bleau, Ahmet Uluer & Gerald B. Pier. (2008) Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends in Molecular Medicine 14:3, pages 120-133.
Crossref
Crossref